Authors: Ponticelli, C Yussim, A Cambi, V Legendre, C Rizzo, G Salvadori, M Kahn, D Kashi, H Salmela, K Fricke, L Heemann, U Garcia-Martinez, J Lechler, R Prestele, H Girault, D

Citation: C. Ponticelli et al., A randomized, double-blind trial of basiliximab immunoprophylaxis plus triple therapy in kidney transplant recipients, TRANSPLANT, 72(7), 2001, pp. 1261-1267

Authors: Higgins, RM Hart, P Lam, FT Kashi, H

Citation: Rm. Higgins et al., Conversion from tacrolimus to cyclosporin in stable renal transplant patients: Safety, metabolic changes, and pharmacokinetic comparison, TRANSPLANT, 70(1), 2000, pp. 199-202

Authors: Higgins, RM Hart, P Lam, FT Kashi, H

Citation: Rm. Higgins et al., Conversion from tacrolimus to cyclosporine in stable renal transplant patients - Safety, metabolic changes, and pharmacokinetic comparison, TRANSPLANT, 69(8), 2000, pp. 1736-1739

Authors: Higgins, RM Morlidge, C Magee, P McDiarmaid-Gordon, A Lam, FT Kashi, H

Citation: Rm. Higgins et al., Conversion between cyclosporin and tacrolimus - 30-fold dose prediction, NEPH DIAL T, 14(6), 1999, pp. 1609-1609